Distributor inventory

Type 2 diabetes mellitus (adjunct to diet and exercise) to control post‑meal (postprandial) blood glucose; used alone or with other antidiabetic medicines (e.g., metformin, sulfonylureas, insulin).

Voglibose is an alpha‑glucosidase inhibitor that delays the breakdown and absorption of carbohydrates in the intestine. This reduces the rise in blood sugar after meals and helps improve overall glycaemic control.

Oral tablet. Take just before the start of each main meal as prescribed by the doctor; swallow with water. If you skip a meal, skip the dose. Follow diet/exercise advice and monitor blood glucose.

Flatulence, abdominal pain, diarrhea, nausea, bloating, indigestion

Use with caution in patients with inflammatory bowel disease, intestinal obstruction, chronic intestinal disorders, or severe renal/hepatic impairment. Risk of hypoglycaemia increases when combined with sulfonylureas or insulin; treat low sugar with glucose (dextrose) rather than sucrose. Monitor blood glucose/HbA1c; stop and seek care if severe abdominal symptoms occur. Not for type 1 diabetes or diabetic ketoacidosis.

Insulin, sulfonylureas (e.g., glimepiride), other antidiabetics (additive hypoglycaemia); digestive enzyme preparations (amylase/pancreatin) and intestinal adsorbents may reduce effect; corticosteroids, thiazide diuretics, thyroid hormones and sympathomimetics may worsen glycaemic control.

Store below 25°C in a dry place, protected from light and moisture. Keep in original pack and out of reach of children.

Voglibose 0.2 mg tablets (generic), Volibo 0.2 Tablet, Voglinorm 0.2 Tablet, Vobose 0.2 Tablet (other pack), Vogli 0.2 Tablet